AKT1 and endometritis: It should be noted that whether in vivo or in vitro, blocking the PI3K/AKT pathway with LY294002 or activating ERS with TM cannot completely eliminate the effect of naringin on endometritis, which may be due to their inability to completely inhibit the PI3K/AKT pathway.